CD274 and neoplasm: While PDL-1 and PD1 expression on tumor cells and their microenvironment cells is highly variable, clinical data are suggestive of high and prolonged efficacy: as an example, in a series of four patients with R/R PCNSL and one with CNS relapse of a testicular lymphoma, all patients responded to nivolumab, with one PR and four CRs.